Click this link to read a post I like on the clusterheadaches.com message board...

Apr 19^th, 2024 at 11:41am

	Welcome, Guest. Please Login or Register
	Search box updated Dec 3, 2011... Search ch.com with Google!

New CH.com Forum › Daily Chat › General Posts › Teva Scraps Chronic Cluster Headache Study

(Moderators: Mrs Deej, DJ)

‹ Previous Topic | Next Topic ›

Pages: 1

Teva Scraps Chronic Cluster Headache Study (Read 1711 times)

Mike NZ

CH.com Hall of Famer

Offline

Oxygen rocks! D3 too!

Posts: 3785
Auckland, New Zealand
Gender: male

Teva Scraps Chronic Cluster Headache Study
Jun 16^th, 2018 at 11:13pm

Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

Quote:

Teva Pharmaceuticals has a new headache. As the Israel-based company pushes forward with its cost-cutting strategies, the company reported it is scrapping its chronic cluster headache program with fremanezumab following a pre-specified futility analysis of that study.

This morning the Israel-based company announced the analysis revealed the primary endpoint of mean change from baseline in the monthly average number of cluster headache attacks during the 12-week treatment period is unlikely to be met. There were no safety concerns with the CGRP inhibitor. With the disappointing news in hand, Teva said it will discontinue the chronic cluster headache trial. A long-term safety study in chronic cluster headaches with fremanezumab will also be discontinued, Teva said.

Interesting that the drug isn't working for chronic CH, but it is making a difference for migraine.

IP Logged

Click Here to visit the CH.com Facebook page!

Mike NZ

CH.com Hall of Famer

Offline

Oxygen rocks! D3 too!

Posts: 3785
Auckland, New Zealand
Gender: male

Re: Teva Scraps Chronic Cluster Headache Study
Reply #1 - Jun 16^th, 2018 at 11:14pm

Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

Quote:

Alder Biopharma (ALDR +14.8%) is up on almost 40% higher volume as investors believe that Teva's exit from developing CGRP inhibitor fremenezumab for chronic cluster headache is a positive for Alder's CGRP inhibitor eptinezumab, in Phase 3 development for chronic and episodic migraine.

So whilst the one above didn't work, this one might...

IP Logged

Peter510 CH.com Alumnus Offline Don't give out... But don't give in. Posts: 966 Wexford. Ireland Gender:	Re: Teva Scraps Chronic Cluster Headache Study Reply #2 - Jun 17^th, 2018 at 5:19am Very interesting Mike. Thanks for the post. Peter.
Back to top	You don't stop laughing because you grow old....You grow old because you stop laughing. IP Logged

Mike NZ

CH.com Hall of Famer

Offline

Oxygen rocks! D3 too!

Posts: 3785
Auckland, New Zealand
Gender: male

Re: Teva Scraps Chronic Cluster Headache Study
Reply #3 - Jun 17^th, 2018 at 10:07pm

Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

Quote:

The episodic cluster headache study is not affected and continues as planned.

So it is just the study for chronic CH that has been discontinued and not the episodic one, but no real information as to why one and not the other.

IP Logged

Sean McE

CH.com Veteran

Offline

I Love CH.com!

Posts: 143
Seattle, Wa
Gender: male

Re: Teva Scraps Chronic Cluster Headache Study
Reply #4 - Jun 18^th, 2018 at 12:16am

Might be a tough study to pull off accurately due to the transitory nature of the beast. I know I've been fooled twice by the coincidental ending of an episode and the starting of a new "cure". One time I started taking St John's wart during a pretty rough episode and that very night I got zero headaches and no more after that either, I was totally convinced I had the bull by the horns. Six months later when they started up again I knew what to take. You already know how that turned out. It was a pretty rude awakening. Angry

Sean

IP Logged

Mike NZ

CH.com Hall of Famer

Offline

Oxygen rocks! D3 too!

Posts: 3785
Auckland, New Zealand
Gender: male

Re: Teva Scraps Chronic Cluster Headache Study
Reply #5 - Jun 18^th, 2018 at 3:07am

I'd have thought that it would be easier to do a study of chronic CH which by its very nature is ongoing and so using a headache diary and some statistical analysis you should be able to compare a baseline (i.e. before the trial) with whatever was given during the trial (drug / placebo).

The real complication would come from trying to do this for people who are episodic as you can't easily differentiate between an cycle that just didn't happen (all too easy with CH variability) and one that was prevented, unless the prevention isn't perfect in which case you'll spot the start / end of a cycle and would need to compare that cycle to previous cycles.

IP Logged

Pages: 1

‹ Previous Topic | Next Topic ›

« Home

‹ Board

Top of this page

©1998-2013 Web Vision Enterprises LLC All rights reserved. All information on this site is protected by international
copyright laws. You may not re-distribute any information from this site without written permission from
Web Vision Enterprises LLC and the webmaster of this site. Violators will be prosecuted.
You may view our privacy policy and financial disclosure statement here

DISCLAIMER: All information contained on this web site is for informational purposes only. It is in no way intended to be used as a replacement for professional medical treatment. clusterheadaches.com makes no claims as to the scientific/clinical validity of the information on this site OR to that of the information linked to from this site. All information taken from the internet should be discussed with a medical professional!